Dyslipidaemia in HIV-1-infected patients receiving protease inhibitors after initial treatment with first-line-based non-nucleoside reverse transcriptase inhibitors: a cross-sectional study

OBJECTIVES: Lipid abnormalities associated with antiretroviral therapy in people with HIV infection are more frequent with protease inhibitors (PI)-based regimens. Whether effects extend to patients receiving a PI subsequent to failure on non-nucleoside reverse-transcriptase inhibitors (NNRTI)-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Pefura Yone, Eric Walter, Kengne, André Pascal, Ashuntantang, Gloria, Betyoumin, Awa Foueudjeu, Ngogang, Jeanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425906/
https://www.ncbi.nlm.nih.gov/pubmed/22874631
http://dx.doi.org/10.1136/bmjopen-2012-001317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425906/
https://www.ncbi.nlm.nih.gov/pubmed/22874631
http://dx.doi.org/10.1136/bmjopen-2012-001317

Ejemplares similares